瑞颂制药 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "瑞颂制药" in Chinese language version.

refsWebsite

Global rank Chinese rank

4web.archive.org

1^st place

1^st place

1medicalnewstoday.com

3,011^th place

3,493^rd place

54^th place

88^th place

1bizjournals.com

407^th place

1,299^th place

1fiercepharma.com

low place

low place

1astrazeneca.com

low place

low place

astrazeneca.com

Acquisition of Alexion completed (新闻稿). AstraZeneca. 2021-07-21 [2021-07-26]. （原始内容存档于2021-07-25）.

bizjournals.com

Don Seiffert. Everything you need to know about the $8.4B acquisition of Synageva. Boston Business Journal. 2015-05-06 [2015-05-08]. （原始内容存档于2020-11-08）.

fiercepharma.com

Higgins-Dunn, Noah. AstraZeneca closes mega $39B Alexion buyout despite antitrust fears, making a splash in rare diseases. FiercePharma. 2021-07-21 [2021-07-26]. （原始内容存档于2021-07-25）.

forbes.com

Alexion Pharmaceuticals on the Forbes World’s Most Innovative Companies List. forbes.com. [2012-09-28]. （原始内容存档于2021-02-01）.

medicalnewstoday.com

Alexion Submits Application for Soliris. 2011-04-08. ^{[失效連結]}

web.archive.org

Alexion Pharmaceuticals on the Forbes World’s Most Innovative Companies List. forbes.com. [2012-09-28]. （原始内容存档于2021-02-01）.
Don Seiffert. Everything you need to know about the $8.4B acquisition of Synageva. Boston Business Journal. 2015-05-06 [2015-05-08]. （原始内容存档于2020-11-08）.
Higgins-Dunn, Noah. AstraZeneca closes mega $39B Alexion buyout despite antitrust fears, making a splash in rare diseases. FiercePharma. 2021-07-21 [2021-07-26]. （原始内容存档于2021-07-25）.
Acquisition of Alexion completed (新闻稿). AstraZeneca. 2021-07-21 [2021-07-26]. （原始内容存档于2021-07-25）.